A University of Alberta pharmacologist is encouraging the trial of common anti-inflammatory medications such as aspirin to treat the most harmful outcomes of COVID-19. Most
Read more
Home ยป
A University of Alberta pharmacologist is encouraging the trial of common anti-inflammatory medications such as aspirin to treat the most harmful outcomes of COVID-19. Most
Read moreMedicare has made two changes that are expected to improve access to continuous glucose monitoring (CGM) devices for beneficiaries with diabetes. Beginning July 18, 2021,
Read more